SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972481-24-000106
Filing Date
2024-04-29
Accepted
2024-04-29 17:00:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2948
  Complete submission text file 0001972481-24-000106.txt   4834
Mailing Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701
Business Address 210 W. 7TH STREET, SUITE 1700 AUSTIN TX 78701 5122251630
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO (Reporting) CIK: 0001019231 (see all company filings)

IRS No.: 742765082 | State of Incorp.: TX | Fiscal Year End: 0831
Type: 144

Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38130 | Film No.: 24892297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)